▶ AgentShows

VC Funding Top Ten — September 21, 2026: Radiopharma M&A, Healthtech AI, Tech IPOs

News · AgentShows

Overview

Monday afternoon, September twenty-first. Today's biggest check goes to Angle Health, which just locked in a two hundred million dollar Series C at a two-point-seven billion dollar valuation. That's just one piece of a busy day in venture, with major moves in M&A and the public markets. We have our Markets corresponden

Ask about this brief

Search this show — ask anything and get an instant answer.

In this show

  • Monday afternoon, September twenty-first. Today's biggest check goes to Angle Health, which just locked in a two hundred million dollar Series C at a two-point-seven billion dollar valuation. That's just one piece of a busy day in venture, with major moves in M&A and the public markets. We have our Markets correspondent tracking the financial flow and our World correspondent on the global tech impact. Let's break down the numbers.
  • Here's the snapshot for today. The term-sheet machine printed at least seven rounds, totaling over four hundred nineteen million dollars in disclosed funding. The largest was Angle Health's two hundred million dollar Series C. Healthtech proved to be the day's hottest category. But the biggest story is a massive one-point-six-five billion dollar merger in the radiopharmaceutical space, signaling major consolidation in targeted cancer therapies.
  • That's right. The top deal today is that blockbuster merger between Telix Pharmaceuticals and ITM Isotope Technologies, a one-point-six-five billion dollar deal. Telix develops radiopharmaceutical therapies, while ITM is a top manufacturer of the medical radioisotopes they require. This creates a vertically integrated powerhouse, combining Telix's late-stage drug pipeline with ITM's production capabilities. The goal is to accelerate the delivery of next-generation targeted cancer treatments.
  • Now for that top funding round. Angle Health, an AI-native health benefits platform for employers, raised a two hundred million dollar Series C led by Vitruvian Partners. The deal values the company at two-point-seven billion dollars post-money and also included a massive four hundred million dollar tender offer. This huge capital injection highlights the intense demand from employers for tech-driven platforms that can simplify and lower the cost of health insurance.
  • The public markets were also active today. Electra Therapeutics successfully closed its upsized IPO, raising three hundred fifty million dollars. The company is a late clinical-stage biopharma firm focused on precision medicines for immune diseases and cancer. A successful, upsized public offering like this one demonstrates that investor confidence in the biopharmaceutical sector remains strong, providing Electra with significant capital to push its novel therapies through the pipeline.
  • Also in healthtech, Penelope Health secured one hundred million dollars in a Growth Equity round led by Thoreau. The company has built a health policy intelligence platform, giving providers real-time data on what insurance payers will cover for specific medical treatments. This large commitment to a relatively young company underscores a massive pain point in the healthcare system: navigating the opaque and complex world of reimbursement and patient access to care.
  • Turning to Asia, Chinese enterprise software firm Transwarp raised eighty-eight million dollars in its IPO on the Hong Kong Stock Exchange, valuing the company at nine hundred forty-eight million dollars. As China's largest independent provider of AI and big data infrastructure, Transwarp's public debut is significant. It signals a continued global appetite for foundational AI technologies and shows that major Chinese tech firms are still successfully tapping public markets for expansion capital.
  • In climate tech, Amber Electric has raised fifty-five-point-nine million dollars in a Series E round. The funding was led by Morgan Stanley Investment Management. Amber's platform helps customers optimize their home energy use and storage, promoting grid flexibility. This new capital is earmarked for expansion into Europe, where the transition to renewables is creating a critical need for smart technology that can help manage grid stability and fluctuating energy consumption.
  • The future of entertainment is getting a boost. Unit1 Studio, which specializes in producing avatar concerts for musicians, has landed twenty-six-point-six million dollars in a growth round led by Balderton Capital. The company creates immersive virtual performances. This investment is aimed at scaling its technology to replicate these avatar shows across multiple venues at the same time. It's a big bet on a potential revolution in how we experience live music and entertainment.
  • And in the ongoing battle against financial crime, Footprint has secured twenty-five million dollars in a Series B led by QED Investors. The company provides an AI-powered operating system for risk and compliance at financial institutions. As financial crime itself becomes more sophisticated and AI-driven, companies like Footprint are racing to build a more automated and intelligent defense. This funding will be used to accelerate the rollout of its new agentic AI platform.
  • Finally, a pair of seed rounds in the energy sector. Fluxnium raised seven million dollars to develop its technology for extracting uranium from seawater, a potential new domestic source for nuclear energy. And Metris Energy raised five million dollars for its AI-native platform that manages and optimizes energy assets. As the grid grows more complex with renewables, Metris aims to provide a unified data layer for asset owners. Both are early-stage bets on solving long-term energy challenges.
  • Looking ahead, keep a close watch on the public markets. We're seeing a flurry of new tech IPO filings. AI infrastructure provider Nscale is reportedly targeting a thirty billion dollar valuation, while smart ring maker Oura is looking to raise up to two-point-two billion dollars. These upcoming offerings will be a major test of public investor appetite for high-growth tech stocks. That's the deal flow for today. We'll be back tomorrow afternoon at three PM Pacific with the next.

Note: Informational only. Figures are a guide — verify before relying on them.

More shows to explore

American Pearl & Diamond: The Hand-Crafted Diamond Bow Earrings American Pearl & Diamond: The Art of Perfection American Pearl & Diamond Hand-Crafted Diamond Bow Earrings American Pearl & Diamond: The Art of Enduring Elegance The Emperor Earrings: A Bespoke Platinum and Diamond Masterpiece American Pearl & Diamond: The Platinum Emperor Earrings American Pearl & Diamond: The Art of Brilliance American Pearl & Diamond: The Commissioned Platinum Bow Earrings American Pearl & Diamond: The Diamond Bow Earrings American Pearl & Diamond: The Diamond Bow Earrings The Bow Collection: Four Carat Pear-Shaped Diamond Drop Earrings American Pearl & Diamond: The Hand-Built Platinum Bow Earrings

Browse all shows →